Researchers at Washington University School of Medicine have developed an experimental immunotherapy they say could change how Alzheimer’s disease is treated — and potentially delayed — particularly for people at highest genetic risk. The approach targets amyloid beta, a sticky protein that builds into nerve-damaging plaques in the brain and is widely believed to play […]
